(Q43035235)

12 November 2017

Liver disease patterns in hemodialysis patients with antibodies to hepatitis C virus (English)

1 reference

12 November 2017

1 reference

1 reference

1 reference

Caramelo C

1

1 reference

12 November 2017

Ortiz A

2

1 reference

12 November 2017

Aguilera B

3

1 reference

12 November 2017

Porres JC

4

1 reference

12 November 2017

Navas S

5

1 reference

12 November 2017

Marriott E

6

1 reference

12 November 2017

Alberola ML

7

1 reference

12 November 2017

Alamo C

8

1 reference

12 November 2017

Galera A

9

1 reference

12 November 2017

Garrón MP

10

1 reference

12 November 2017

1 December 1993

1 reference

American Journal of Kidney Diseases

12 November 2017

1 reference

12 November 2017

22

1 reference

12 November 2017

6

1 reference

12 November 2017

822-828

1 reference

Chronic liver disease developing after outbreak of HBsAG-negative hepatitis in haemodialysis unit

12 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970341-4

7 January 2021

Non-A, non-B hepatitis and chronic dialysis--another dilemma.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970341-4

7 January 2021

Impact of infection control strategies on the incidence of dialysis-associated hepatitis in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970341-4

7 January 2021

An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970341-4

7 January 2021

Hepatitis C virus antibodies among risk groups in Spain

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970341-4

7 January 2021

The prevalence of hepatitis C virus antibodies among hemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970341-4

7 January 2021

Hepatitis C infection in two urban hemodialysis units

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970341-4

7 January 2021

Hepatitis C virus infection among kidney transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970341-4

7 January 2021

Chronic hepatitis in end-stage renal disease: comparison of HBsAg-negative and HBsAg-positive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970341-4

7 January 2021

Comparison of several PCR procedures for detection of serum HCV-RNA using different regions of the HCV genome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970341-4

7 January 2021

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970341-4

7 January 2021

Descartes before the Horse: I Clone, Therefore I Am: The Hepatitis C Virus in Current Perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970341-4

7 January 2021

Treatment of chronic non-A,non-B hepatitis with recombinant human alpha interferon. A preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970341-4

7 January 2021

Is liver biopsy useful in the evaluation of patients with chronically elevated liver enzymes?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970341-4

7 January 2021

Antibody to hepatitis C virus and liver disease in volunteer blood donors

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970341-4

7 January 2021

New kit on the block: Evaluation of second-generation assays for detection of antibody to the hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970341-4

7 January 2021

Hepatitis C viraemia with normal liver histology in symptomless HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970341-4

7 January 2021

Hepatitis C viraemia and liver disease in symptom-free individuals with anti-HCV.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970341-4

7 January 2021

High Rate of Infectivity and Liver Disease in Blood Donors with Antibodies to Hepatitis C Virus

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970341-4

7 January 2021

The Chronic Sequelae of Non-A, Non-B Hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970341-4

7 January 2021

10.1016/S0272-6386(12)70341-4

Identifiers

DOI

1 reference

12 November 2017

1 reference